Replies to post #798398 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

Thanks 
So it is still in some RFI stage I guess .

[seekinganswers]

Julian Beach already confirmed back in the March meeting that there were no longer any backlogs.
The better question would be is (how much longer can NWBO or MHRA drag this process out?)

[10baggerz]

$NWBO Northwest Biotherapeutics has submitted a Marketing Authorization Application (MAA) to the MHRA for DCVax®-L, an immunotherapy for glioblastoma. The MHRA are unable to comment on applications during the process of review, but the MHRA can CONFIRM that this application is NOT AFFECTED BY ANY BACKLOGS.
Here we go again with the BIZARRE “confirmation” that the delay in reviewing the DCVAX-l MAA IS NOT AFFECTED BY ANY BACKLOGS.
This is code for it’s NOT our fault. meaning something about the MAA status CHANGED between 12/11/2023 & 3/31/2025.
Bears will say the MAA was one of the few with major issues referred to CHM
Bulls will say that the MAA was modified to include something positive like Flaskworks, ORBIS, or agnostic.
I actually lean towards the former but in light of the advent news, Dr ashkan’s 2 month estimate, and GZ’s email to Lefty49 on IHUB, I still believe the MAA will be approved this year. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176939596